Overview

Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks

Status:
Recruiting

Trial end date:
2023-12-01

Target enrollment:
0

Participant gender:
All

Summary

Influenza outbreaks are a prevalent event in nursing homes (NHs). We will study baloxavir compared to oseltamivir when used for influenza prophylaxis when facilities identify an index incident case of influenza. This study will help guide nursing home's decision making and demonstrate the effectiveness of a novel antiviral for preventing influenza outbreaks.

Phase:

Phase 4

Accepts Healthy Volunteers?

Accepts Healthy Volunteers

Details

Lead Sponsor:

Insight Therapeutics, LLC

Collaborators:

Brown University
Case Western Reserve University
Genentech, Inc.

Treatments:

Baloxavir
Oseltamivir

Criteria

Inclusion Criteria:

- Medicare-certified NHs in any location in the United States with at least 50 long-stay
residents 18 years of age or older.

- Facilities with at least 80% of their long-stay population 65 years of age or older

Exclusion Criteria:

- Hospital-based facilities

- Facilities not submitting MDS data